EP Patent

EP2568990A4 — Method of producing pleurodesis

Assigned to CareFusion 2200 Inc · Expires 2013-10-09 · 13y expired

What this patent protects

The present invention provides methods of producing pleurodesis in a mammalian subject, comprising administration of a low dosage of a sclerosing agent such as silver or a salt of silver.

USPTO Abstract

The present invention provides methods of producing pleurodesis in a mammalian subject, comprising administration of a low dosage of a sclerosing agent such as silver or a salt of silver.

Drugs covered by this patent

Patent Metadata

Patent number
EP2568990A4
Jurisdiction
EP
Classification
—
Expires
2013-10-09
Drug substance claim
No
Drug product claim
No
Assignee
CareFusion 2200 Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.